Patents by Inventor Anthony Wilkes Burgess

Anthony Wilkes Burgess has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Truncated EGF Receptor
    Publication number: 20090117134
    Abstract: The present invention relates to truncated EGF receptor molecules that exhibit increased binding affinities for EGFR ligands such as EGF and TGF1. The present invention also relates to methods of screening for EGF receptor ligands and methods of treatment which involve the use of these molecules.
    Type: Application
    Filed: October 20, 2008
    Publication date: May 7, 2009
    Applicants: Commonwealth Scientific and Industrial Research Organisation, Ludwig institute for Cancer Research
    Inventors: Colin Wesley WARD, Neil Moreton McKern, George Oscar Lovrecz, Robert Nicholas Jorissen, Thomas Peter John Garrett, Thomas Charles Elleman, Anthony Wilkes Burgess, Timothy Edward Adams, Teresa Anne Domagala, Edouard Nice
  • Truncated egf receptor
    Publication number: 20030108953
    Abstract: The present invention relates to truncated EGF receptor molecules that exhibit increased binding affinities for EGFR ligands such as EGF and TNFI. The present invention also relates to methods of screening for EGF receptor ligands and methods of treatment which involve the use of these molecules.
    Type: Application
    Filed: October 10, 2002
    Publication date: June 12, 2003
    Inventors: Colin Wesley Ward, Neil Moreton McKern, George Oscar Lovrecz, Robert Nicholas Jorissen, Thomas Peter John Garrett, Thomas Charles Elleman, Anthony Wilkes Burgess, Timothy Edward Adams, Teresa Anne Domagala, Edouard Nice